Article Details

MorphImmune, Inc., a Research Bridge Partners Portfolio Company, Appoints Ronald Martell as ...

Retrieved on: 2021-06-08 11:15:00

Tags for this article:

Click the tags to see associated articles and topics

MorphImmune, Inc., a Research Bridge Partners Portfolio Company, Appoints Ronald Martell as .... View article details on hiswai:

Excerpt

... company that is advancing a highly specific targeting technology that uses a ligand-linked payload to reprogram the immune system, announced the ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up